Man Group
MNTA

Man Group’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Man Group’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-324,858
Closed -$17M – 2024
2020
Q3 		$17M Buy
324,858
+19,348
+6% +$801K 0.07% 311
2020
Q2 		$10.2M Buy
305,510
+242,525
+385% +$7.72M 0.05% 357
2020
Q1 		$1.71M Sell
62,985
-85,432
-58% -$2.38M 0.01% 944
2019
Q4 		$2.93M Buy
148,417
+2,708
+2% +$43.3K 0.01% 1203
2019
Q3 		$1.89M Buy
145,709
+22,433
+18% +$271K 0.01% 1265
2019
Q2 		$1.53M Sell
123,276
-3,400
-3% -$45.1K 0.01% 1392
2019
Q1 		$1.84M Sell
126,676
-96,642
-43% -$1.23M 0.01% 1371
2018
Q4 		$2.46M Buy
223,318
+215,718
+2,838% +$3M 0.01% 1117
2018
Q3 		$200K Sell
7,600
-44,078
-85% -$1.19M ﹤0.01% 2023
2018
Q2 		$1.06M Buy
51,678
+22,078
+75% +$474K ﹤0.01% 1591
2018
Q1 		$537K Buy
+29,600
New +$493K ﹤0.01% 1702

Man Group's MNTA Position: Q4 2020 in Review

Man Group sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 324,858 shares — an estimated $17M sold.

Man Group first reported a position in MNTA in Q1 2018 and held it in 11 quarters. The position peaked at $17M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Man Group reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Man Group sold 324,858 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $17M.
  • Man Group first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2018 and held it in 11 quarters.
  • Man Group's Momenta Pharmaceuticals, Inc. position peaked at $17M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Man Group's 13F filing for Q4 2020, filed 16 Feb 2021.